LEN
52
2
FMC
36
3
QRVO
61
-13
CSX
55
5
EMC
89
-4
JNJ
32
9
VFC
35
-15
MU
58
22
EA
44
-2
CMI
60
-3
TDC
80
13
GME
71
6
EOG
52
2
FE
39
-2
ADT
43
-7
PSA
43
-12
PWR
53
-8
WY
34
-5
MCD
38
-16
GIS
41
-2
LEN
52
2
FMC
36
3
QRVO
61
-13
CSX
55
5
EMC
89
-4
JNJ
32
9
VFC
35
-15
MU
58
22
EA
44
-2
CMI
60
-3
TDC
80
13
GME
71
6
EOG
52
2
FE
39
-2
ADT
43
-7
PSA
43
-12
PWR
53
-8
WY
34
-5
MCD
38
-16
GIS
41
-2
Financhill
Back

Autolus Therapeutics PLC Quote, Financials, Valuation and Earnings

Nvidia's march to $5 trillion

Click here to see how Nvidia's march to $5 trillion could impact its partners.
Sell
24

AUTL
Autolus Therapeutics PLC

Last Price:
3.42
Seasonality Move:
-14.93%

7 Day Trial

ALL ACCESS PASS

$ 7

This New Idea is Set to Shock the World

Click here to learn all the details.

Autolus Therapeutics PLC Price Quote

$3.42
-0.05 (-1.44%)
(Updated: July 2, 2024 at 10:25 AM ET)

Autolus Therapeutics PLC Key Stats

Sell
24
Autolus Therapeutics PLC (AUTL) is a Sell
Day range:
$3.37 - $3.55
52-week range:
$2.01 - $7.45
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.59%
Volume:
494.9K
Avg. volume:
1.4M
1-year change:
45.8%
Market cap:
$923.1M
Revenue:
$1.7M
EPS:
$-1.21

How Much Does Autolus Therapeutics PLC Make?

Data Unavailable

Is Autolus Therapeutics PLC Growing As A Company?

Autolus Therapeutics PLC Stock Price Performance

What Is Autolus Therapeutics PLC 52-Week High & Low?

Autolus Therapeutics PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Autolus Therapeutics PLC?

Is Autolus Therapeutics PLC Cash Flow Positive?

  • What Is AUTL Cash Flow From Operations?
    Cash flow from operations (TTM) is -$143.7M
  • What Is Autolus Therapeutics PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $561.2M
  • What Is Autolus Therapeutics PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$7.9M

Autolus Therapeutics PLC Return On Invested Capital

  • Is Management Doing A Good Job?
    AUTL return on invested capital is -80.74%
  • What Is Autolus Therapeutics PLC Return On Assets?
    ROA measures how assets are converting to revenues and is -42.65%
  • What Is AUTL Return On Equity?
    ROE is a measure of profitability and is -80.74%

Autolus Therapeutics PLC Earnings Date & Stock Price

Autolus Therapeutics PLC Competitors

Autolus Therapeutics PLC Dividend Yield

Data Unavailable

Autolus Therapeutics PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -76.47%
Revenue: 681.04% -59.71%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 10.54
Upside from Last Price: 203.87%

Major Shareholders

  • How many AUTL shares are owned by institutional investors?
    189.9M AUTL shares are owned by institutional investors
  • How many AUTL shares are owned by insiders?
    0 AUTL shares are owned by insiders